Estradiol (雌二醇; E2)是哺乳动物雌激素。
Estradiol (E2) is a potent mammalian estrogenic hormone that is produced in the ovaries (by the granulosa cells), placenta, testis and possibly the adrenal cortex. Estradiol is an endogenous estrogenic hormone receptor (ER) agonist (Ki values are 0.12 and 0.13 nM for ERα and ERβ respectively). Also high affinity ligand at membrane estrogen GPR30 receptors. Estradiol is an activator of PI 3-kinase.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Woolley CS, et al. J Neurosci, 1997, 17(5), 1848-1859.
[2] Thomas et al (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 624.
[3] Kuiper et al (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 863.
分子式 C18H24O2 |
分子量 272.38 |
CAS号 50-28-2 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 100 mM |
Water <1 mg/mL |
Ethanol 75 mM |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01923298 | Estrogen Levels Among Breast Cancer Patients | Drug: Estradiol | University of Arizona | Phase 2 | 2013-08-09 | 2017-02-03 |
NCT01753102 | Vulvar Atrophy|Vaginal Atrophy | Drug: Estradiol | Sun Pharmaceutical Industries Limited | Phase 3 | 2012-11-01 | 2015-05-19 |
NCT00744328 | Postpartum Depression | Drug: Transdermal Estradiol|Drug: Sertraline|Other: Placebo | Northwestern University | Phase 4 | 2008-08-01 | 2014-10-20 |
NCT00167648 | Cancer|Prostate Neoplasms | Drug: Leuprolide or goserelin|Drug: Transdermal estradiol | University of Washington|Pacific Northwest SPORE (Specialized Projects in Oncology Research Excellence) | Phase 2 | 2005-03-01 | 2009-01-15 |
NCT01109979 | Cardiovascular Diseases | Drug: Estradiol+MPA|Drug: Estradiol+Drospirenone | Brigham and Women's Hospital|Bayer | Phase 4 | 2009-12-01 | 2016-06-10 |
NCT02485821 | Failed Induction of Labor | Drug: Estradiol|Drug: Placebo|Drug: Misoprostol | Ain Shams University | Phase 2|Phase 3 | 2015-06-01 | 2016-02-14 |
NCT02238808 | Estrogen Receptor Positive Breast Cancer | Drug: Estradiol | AHS Cancer Control Alberta | Phase 2 | 2015-08-01 | 2017-01-04 |
NCT01218386 | Infertility | Drug: Estradiol valerate | Universitair Ziekenhuis Brussel | Phase 4 | 2010-05-01 | 2012-03-27 |
NCT00775242 | Menopause | Drug: Estradiol and Progesterone|Drug: Estradiol and Progesterone | Centro A.F. de Estudios Tecnologicos, S.A. | Phase 2|Phase 3 | 2007-04-01 | 2009-08-21 |
NCT00789802 | Contraception|Bleeding | Drug: transdermal estradiol|Drug: naproxen|Drug: oral placebo | Washington University School of Medicine|American College of Obstetricians and Gynecologists | 2008-11-01 | 2014-12-08 | |
NCT02792153 | Anorexia Nervosa | Drug: Estradiol | Johns Hopkins University | Phase 1 | 2016-12-01 | 2016-12-12 |
NCT01597986 | Pharmacokinetics of Isavuconazole|Pharmacokinetics of Ethinyl Estradiol and Norethindrone|Healthy Volunteers | Drug: isavuconazole|Drug: Oral Contraceptive (ethinyl estradiol / norethindrone) | Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd|Astellas Pharma Inc | Phase 1 | 2012-04-01 | 2012-07-12 |
NCT00870220 | Turner's Syndrome | Drug: Norditropin, Menostar 14mcg patch, Vivelle dot 25mcg patch | University of Chicago|Novo Nordisk A/S|University of Michigan|Johns Hopkins University|Massachusetts General Hospital|University of Oklahoma|University of South Florida|Thomas Jefferson University | Phase 1 | 2009-04-01 | 2014-03-10 |
NCT02255396 | Non-obstructive Azoospermia With Testicular Biopsy for Spermatozoa Extraction | Other: ESTRADIOL | University Hospital, Clermont-Ferrand | 2009-01-01 | 2014-09-30 | |
NCT00324259 | Breast Neoplasms | Drug: Estradiol | Washington University School of Medicine | Phase 2 | 2004-08-01 | 2015-01-29 |
NCT01779947 | Atrophic Vaginitis Due to Menopause | Drug: Estradiol Vaginal Tablets 10 mcg|Drug: placebo | Amneal Pharmaceuticals, LLC | Phase 3 | 2012-03-01 | 2014-06-25 |
NCT02638922 | Constitutional Tall Stature | Drug: Estradiol | Rigshospitalet, Denmark | 2014-01-01 | 2016-04-05 | |
NCT00698035 | Sexual Dysfunction, Physiological | Drug: Testosterone Cream|Drug: Estring | University of California, San Francisco | Phase 2 | 2007-03-01 | 2014-05-27 |
NCT02255175 | Perimenopausal Depression | Drug: Estradiol|Drug: Progesterone | University of North Carolina, Chapel Hill|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute of Mental Health (NIMH) | Phase 4 | 2015-10-01 | 2016-05-04 |
NCT00114517 | Atherosclerosis | Drug: Oral 17B-estradiol|Drug: Placebo | University of Southern California|National Institute on Aging (NIA) | Phase 2|Phase 3 | 2004-07-01 | 2010-06-17 |
NCT02677259 | IVF | Drug: 17-beta estradiol|Drug: Micronized progesterone | One Fertility | Phase 2 | 2016-05-01 | 2016-02-09 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们